Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
West China Hospital
West China Hospital
University of Chicago
DEKA Biosciences
Thomas Jefferson University
The Netherlands Cancer Institute
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
University of Cincinnati
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Cincinnati
University of Colorado, Denver
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Curis, Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Miami
National Cancer Institute (NCI)
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)